Showing 6901-6910 of 23151 results for "".
Improving Conduit and Neobladder Efficiency: Surgical and Post-Operative Strategies
https://reachmd.com/programs/clinicians-roundtable/Improving-conduit-and-neobladder-efficiency-surgical-and-post-operative-strategies/33038/Optimizing urinary diversion and continence techniques is essential for improving patient outcomes and quality of life following surgery. Join Dr. Mutahar Ahmed as he provides expert guidance on improving success in conduits and neobladders in the operating room and beyond. Dr. Ahmed is the DirectorUnderstanding Schizophrenia: The Role of Neurotransmission and Inflammation
https://reachmd.com/programs/neurofrontiers/understanding-schizophrenia-the-role-of-neurotransmission-and-inflammation/36637/Our understanding of schizophrenia’s pathophysiology continues to evolve, highlighting the complex interplay between neurotransmitter dysregulation, inflammation, and progressive gray matter loss. Learn more with Dr. Jeffrey Lieberman, the Constance and Stephen Lieber Professor of Psychiatry at ColuRethinking Pain: Care Strategies for Patients with Rheumatic Diseases
https://reachmd.com/programs/living-rheum/rethinking-pain-care-strategies-for-patients-with-rheumatic-diseases/30077/Learn how to distinguish between nociceptive, nociplastic, and neuropathic pain in patients with rheumatic diseases.MacTel Type 2: A Misnomer?
https://reachmd.com/programs/cme/MacTel-Type-2-A-Misnomer/35969/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
https://reachmd.com/programs/eye-on-ocular-health/evaluating-eyelid-wipes-for-dry-eye-disease-clinical-trial-insights/37276/A recent study presented at the 2025 American Academy of Ophthalmology Annual Meeting evaluated a novel treatment option for dry eye disease: a TRPM8 agonist delivered via an eyelid wipe. Hear Dr. Houman D. Hemmati walk through the study's design, its findings on safety and efficacy, and the next stGenomic Profile of ER+ HER2- Metastatic Invasive Lobular Carcinoma
https://reachmd.com/programs/project-oncology/genomic-profile-metastatic-invasive-lobular-carcinoma/36168/Invasive lobular carcinoma is a prevalent but underrecognized breast cancer subtype with distinct characteristics that set it apart from invasive carcinoma of no special type. To gain a better understanding of this subtype, a recent study presented at the 2025 San Antonio Breast Cancer Symposium exaOptimizing Surgical Wound Outcomes: A Focus on Evidence-Based Care
https://reachmd.com/programs/clinicians-roundtable/optimizing-surgical-wound-outcomes-a-focus-on-evidence-based-care/35841/Successful surgical wound care goes beyond closure—it’s also about minimizing complications, reducing readmissions, and aligning with patient-reported outcomes like pain control and daily activity readiness. Hear from Ms. Kara Couch as she explores how standardization, documentation, and evidence-baRedefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
https://reachmd.com/programs/frontlines-prostate-cancer/redefining-mhspc-treatment-from-monotherapy-to-triplet-therapy-regimens/32220/Androgen deprivation therapy (ADT) plus an androgen receptor pathway inhibitor (ARPi) is increasingly considered the standard of care for most patients with metastatic hormone-sensitive prostate cancer (mHSPC), but ADT monotherapy is still reserved for well-justified exceptions. And moving forward,COPD in Japan vs. the US: Comparing Prevalence and Mortality Rates
https://reachmd.com/programs/frontlines-copd/copd-in-japan-vs-the-us-comparing-prevalence-and-mortality-rates/35533/Despite its historically higher smoking rates, Japan has significantly lower COPD prevalence and mortality than the United States. But incorporating certain elements of the Japanese diet and implementing public health practices may help reverse this paradox. Joining Dr. Charles Turck to share the fiExploring Metabolomics in Multiple Sclerosis
https://reachmd.com/programs/neurofrontiers/exploring-metabolomics-in-multiple-sclerosis/32372/Hear about how multiple sclerosis is associated with changes in the metabolome, which could inform diagnosis and management.